With reference to Increase in Volume, FDC has clarified that the Company has been complying with all the provisions of the Listing Agreement and has been promptly intimating the Exchanges, information pertaining to the operation/ performance of the Company, which includes all price sensitive information. Further, they are not aware of reasons for increase in volume of Shares of the Company. It appears to us, that the market is quite favourable for Pharmaceutical Companies since the last few days. Kindly note, that as and when any information becomes material in nature or any material transaction is finally executed by the company, the same will be promptly intimated to the Exchanges within the given timelines.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: